PHARMACOKINETICS OF N-4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
作者：
UEDA, T
NAKAMURA, T
ANDO, S
KAGAWA, D
SASADA, M
UCHINO, H
JOHNO, I
AKIYAMA, Y
机构：
[1] KYOTO UNIV,FAC MED,DEPT PHARM,KYOTO 606,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT PEDIAT,KYOTO 606,JAPAN
[3] FUKUI MED SCH,DEPT MED,MATSUOKA,FUKUI 91011,JAPAN
来源：
CANCER RESEARCH | 1983年 / 43卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3412 / 3416
页数：5
相关论文
共 50 条
[21]   MODULATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE METABOLISM BY THYMIDINE IN HUMAN ACUTE-LEUKEMIA [J].
ZITTOUN, R ;
ZITTOUN, J ;
MARQUET, J ;
RUSTUM, Y ;
CREAVEN, P .
CANCER RESEARCH, 1985, 45 (10) :5186-5192
[22]   INTRACELLULAR PHARMACOKINETICS OF N4-BEHENOYL-1-BETA-D-ARABINO-FURANOSYLCYTOSINE [J].
HIGASHIGAWA, M ;
HORI, H ;
OCHIAI, H ;
OHKUBO, T ;
KAWASAKI, H ;
NOBORI, T ;
KAMIYA, H ;
SAKURAI, M .
PURINE AND PYRIMIDINE METABOLISM IN MAN VI, PT B: BASIC RESEARCH AND EXPERIMENTAL BIOLOGY, 1989, 253 :341-348
[23]   4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN COMBINATION WITH 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE-LEUKEMIA [J].
BERMAN, E ;
RAYMOND, V ;
DAGHESTANI, A ;
ARLIN, ZA ;
GEE, TS ;
KEMPIN, S ;
HANCOCK, C ;
WILLIAMS, L ;
STEVENS, YW ;
CLARKSON, BD ;
YOUNG, C .
CANCER RESEARCH, 1989, 49 (02) :477-481
[24]   INVIVO DISTRIBUTION OF C-14-LABELED N4-BEHENOYL-1-BETA-D-ARABINOFURANOSYLCYTOSINE IN MICE [J].
TOYOSHIMA, S ;
FUKUMA, M ;
SETO, Y ;
FUJITA, H ;
FUKUSHIMA, K ;
TOMIOKA, H ;
SAKURAI, T ;
SUGIMOTO, Y ;
YAGI, T ;
HOSHINO, T ;
SOWA, T .
GANN, 1981, 72 (01) :19-29
[25]   BIOCHEMICAL PHARMACOLOGY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDHOOD ACUTE-LEUKEMIA [J].
AVRAMIS, VI ;
BIENER, R ;
KRAILO, M ;
FINKLESTEIN, J ;
ETTINGER, L ;
WILLOUGHBY, M ;
SIEGEL, SE ;
HOLCENBERG, JS .
CANCER RESEARCH, 1987, 47 (24) :6786-6792
[26]   Close correlation of 1-β-D-arabinofuranosylcytosine 5′-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N4-behenoyl-1-β-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia [J].
Yamauchi, T ;
Kawai, Y ;
Goto, N ;
Kishi, S ;
Imamura, S ;
Yoshida, A ;
Urasaki, Y ;
Fukushima, T ;
Iwasaki, H ;
Tsutani, H ;
Masada, M ;
Ueda, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (09) :975-982
[27]   TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA BY CONCURRENT ADMINISTRATION OF N-4-BEHENOYL-L-BETA-D-ARABINOFURANOSYLCYTOSINE, ACLACINOMYCIN-A, 6-MERCAPTOPURINE AND PREDNISOLONE - A PILOT-STUDY [J].
HIRANO, M ;
MORISHITA, Y ;
INO, T ;
MATSUI, T ;
SHIMIZU, S ;
SHIGEMURA, H ;
NAKAMURA, K ;
ONO, Y ;
SAITO, M .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1981, 11 (01) :87-92
[28]   PHARMACOKINETICS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN HUMANS [J].
WAN, SH ;
HUFFMAN, DH ;
AZARNOFF, DL ;
HOOGSTRATEN, B ;
LARSEN, WE .
CANCER RESEARCH, 1974, 34 (02) :392-397
[29]   INVIVO CELLULAR KINETIC AND PHARMACOLOGICAL STUDIES OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND 3-DEAZAURIDINE CHEMOTHERAPY FOR RELAPSING ACUTE-LEUKEMIA [J].
BARLOGIE, B ;
PLUNKETT, W ;
RABER, M ;
LATREILLE, J ;
KEATING, M ;
MCCREDIE, K .
CANCER RESEARCH, 1981, 41 (03) :1227-1235
[30]   PHARMACOKINETIC STUDIES OF INTERMEDIATE-DOSE TO HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE IN CHILDREN WITH ACUTE-LEUKEMIA AND LYMPHOMA [J].
TAKASHIMA, Y ;
MATSUYAMA, K .
JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (04) :330-333
12345